Related Experiment Video
Updated: May 20, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
An unusual recurrence site for HCC!
Edouard Auclin1, Cécile Camiliéri, Olivier Dubreuil
1Digestive oncology department, European hospital Georges-Pompidou, AH-PH, Paris, France. ed.auclin@gmail.com
Background:
Hepatocellular carcinoma (HCC) is the first malignant hepatic tumor in frequency, with an incidence of 10 new cases per 100,000 people a year, in France. HCC metastasis disseminate hematogenously. The most frequent metastatic sites are lungs, bones, and liver.
Patients And Methods:
We detail the approach to diagnosis and the treatment of a patient with an unusual late recurrence of HCC, which was discovered fortuitously. The metastasis was located in the subcutaneous tissue of the right gluteal fold.
Conclusion:
This case poses a problem of detection in the clinical practice. Indeed, the recurrence occurred 9 years after the HCC. Molecular analysis of our case could make us progress in our knowledge of this disease, and to associate it to a patient's group with similar HCC evolutive profile.
Related Concept Videos
Hepatitis
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
